# Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

> **NCT01677988** · PHASE2 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 3 (actual)

## Conditions studied

- Adenocarcinoma of Head of Pancreas

## Interventions

- **DRUG:** Neo-adjuvant Chemotherapy
- **RADIATION:** Chemoradiation
- **PROCEDURE:** Surgical Resection

## Key facts

- **NCT ID:** NCT01677988
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study was terminated due to low accrual.
- **Last updated:** 2016-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677988, "Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01677988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*